Convalescent Plasma to Treat COVID-19: A Two-Center, Randomized, Double-Blind Clinical Trial.

Yanet Ventura-EnríquezCarlos Cabello-Gutiérrez Angel Augusto Pérez-CalatayudEvelyn Cortina-De la RosaChristian Javier Fareli-GonzálezPaola Castillo-JuárezAlberto Peña-Pérez CarlosElí Omar Zavaleta-MartínezElizabeth Diaz-PadillaSandra MurrietaVioleta Deyanira Álvarez-JiménezJuan Alberto Díaz Ponce-MedranoCatalina Casillas-SuárezMaría Angelica Ocampo-OcampoCruz Vargas-de-León Verónica Fernández-Sánchez

Published in: Life (Basel, Switzerland) (2022)

CP is safe and effective, as it decreased mortality in the CP group compared with the control group.

Keyphrases

double blind
clinical trial
placebo controlled
phase iii
phase ii
open label
coronavirus disease
sars cov
study protocol
cardiovascular events
risk factors
type diabetes
coronary artery disease
respiratory syndrome coronavirus
cardiovascular disease